Sprint Bioscience congratulates Yoshinori Ohsumi on the Nobel prize
At Sprint Bioscience we are very happy that a field of research that we have actively pursued for more than 5 years is now being rewarded the Nobel prize in medicine.Sprint Bioscience is a Swedish company that since the start has been running a project for autophagy inhibition for cancer treatment. The project is targeting a key protein for autophagy initiation, Vps34. By collaborations, international and in Sweden, Sprint Bioscience has built a world class expertise within autophagy and its role in cancer. The scientific advisors of the company, Dr Ravi Amaravadi, was visiting Sweden last